Feeds

Boffins develop working MALE PILL

For mice and (maybe soon) men

Bridging the IT gap between rising business demands and ageing tools

Stateside boffins think that they may have delivered a long-sought boon: a male oral contraceptive without undesirable side effects.

There are already drugs which men can take to render sex a mildly athletic recreational activity rather than a potentially life-altering financial and emotional commitment, but these generally have disadvantages severe enough that they have failed to catch on. Their effectiveness sometimes varies across different ethnic groups, for instance, and they occasionally take away their own purpose by removing desire as well as consequences.

But then Professor Debra Wolgemuth noticed a study by a drug company into the effects of a compound being tested as a skin treatment. The drug company lost interest in the stuff after noting that it seemed to affect the male wedding tackle in such a way as to prevent reproduction.

But "we were intrigued," says Wolgemuth. "One company's toxin may be another person's contraceptive."

The compound works by interfering with retinoic acid receptors (RARs), whose action is necessary for a chap to produce sperm: it is known as a RAR antagonist. According to Wolgemuth and her colleagues, tests in mice indicate that it could be the male pill at last. And temporary RAR-busting Jaffa-isation appears to cause no trouser-department floppening or other undesirable side effects.

"We have seen no side effects, so far, and our mice have been mating quite happily," reports the prof.

"It can be taken orally as a pill, avoiding the injection process. It also appears to have a very rapid effect on sperm production and an even more rapid recovery when fertility is desired," adds Wolgemuth's fellow researcher Dr Sanny Chung.

More trials and tests will be needed, of course, but the prospect of a working pill for blokes seems to be on the cards "in the not so distant future", according to Chung.

The details of the study are published here in the journal Endocrinology. ®

Mobile application security vulnerability report

More from The Register

next story
Malaysian Airlines flight MH17 claimed lives of HIV/AIDS cure scientists
Researchers, advocates, health workers among those on shot-down plane
Mwa-ha-ha-ha! Eccentric billionaire Musk gets his PRIVATE SPACEPORT
In the Lone Star State, perhaps appropriately enough
All those new '5G standards'? Here's the science they rely on
Radio professor tells us how wireless will get faster in the real world
The Sun took a day off last week and made NO sunspots
Someone needs to get that lazy star cooking again before things get cold around here
Boffins discuss AI space program at hush-hush IARPA confab
IBM, MIT, plenty of others invited to fill Uncle Sam's spy toolchest, but where's Google?
Microsoft's anti-bug breakthrough: Wire devs to BRAIN SCANNERS
Clippy: It looks your hands are shaking, are you sure you want to commit this code?
prev story

Whitepapers

Designing a Defense for Mobile Applications
Learn about the various considerations for defending mobile applications - from the application architecture itself to the myriad testing technologies.
How modern custom applications can spur business growth
Learn how to create, deploy and manage custom applications without consuming or expanding the need for scarce, expensive IT resources.
Reducing security risks from open source software
Follow a few strategies and your organization can gain the full benefits of open source and the cloud without compromising the security of your applications.
Boost IT visibility and business value
How building a great service catalog relieves pressure points and demonstrates the value of IT service management.
Consolidation: the foundation for IT and business transformation
In this whitepaper learn how effective consolidation of IT and business resources can enable multiple, meaningful business benefits.